Prediction of pathological response grading for esophageal squamous carcinoma after neoadjuvant chemoradiotherapy based on MRI imaging using PDX

Prediction of pathological response grading for esophageal squamous carcinoma after neoadjuvant chemoradiotherapy based on MRI imaging using PDX

IntroductionTo confirm the efficacy of magnetic resonance-diffusion weighted imaging (MR-DWI) in esophageal squamous cell carcinoma (ESCC) early pathological response prediction and assessment to neoadjuvant chemoradiotherapy (nCRT) using patient-derived xenografts (PDXs)MethodsPDX-bearing mice were...

Full description

Bibliographic Details
Main Authors:	Jingzhen Shi, Jianbin Li, Zhenxiang Li, Yankang Li, Liang Xu, Yingjie Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Oncology
Subjects:	patient-derived xenograft esophageal squamous cell carcinoma magnetic resonance-diffusion weighted imaging pathological response grading neoadjuvant chemoradiotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1160815/full

Similar Items

Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
by: Jingzhen Shi, et al.
Published: (2020-07-01)

Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
by: Jingzhen Shi, et al.
Published: (2020-11-01)

Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
by: Fei Chen, et al.
Published: (2022-08-01)

Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
by: Magnus Nilsson, et al.
Published: (2022-07-01)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Guihong Liu, et al.
Published: (2024-03-01)

Predictive value of neutrophil-lymphocyte ratio in preoperative neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: XIONG Kai, et al.
Published: (2021-01-01)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
by: Lei Xu, et al.
Published: (2022-11-01)

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
by: Wenwu He, et al.
Published: (2022-06-01)

A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Ding T, et al.
Published: (2021-10-01)

Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial designCentral MessagePerspective
by: Yuyan Zheng, MD, et al.
Published: (2022-03-01)

Effect of circumferential resection margin status on survival and recurrence in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
by: Yi-Min Gu, et al.
Published: (2022-09-01)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
by: Zhao J, et al.
Published: (2023-08-01)

Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy
by: Mingrui Shao, et al.
Published: (2019-03-01)

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinomaResearch in context
by: Jing Wen, et al.
Published: (2022-12-01)

Predictive Value of Endoscopic Observations and Biopsy After Neoadjuvant Chemoradiotherapy in Assessing the Pathologic Complete Response of Patients With Esophageal Squamous Cell Carcinoma
by: Ali Taghizadeh Kermani, et al.
Published: (2022-05-01)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
by: Chu-Pin Pai, et al.
Published: (2022-08-01)

Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study
by: Xing Gao, et al.
Published: (2022-05-01)

High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: an endemic area population-based study
by: Chia-Chin Li, et al.
Published: (2022-11-01)

Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery
by: Yun Luo, et al.
Published: (2022-07-01)

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
by: Wing-Keen Yap, et al.
Published: (2022-11-01)

Impact of Perineural Invasion and Preexisting Type 2 Diabetes on Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy
by: Nai-Wen Su, et al.
Published: (2023-02-01)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)

Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis
by: Yusuke Sato, et al.
Published: (2021-02-01)

Preliminary study on involving field irradiation radiotherapy in neoadjuvant chemoradiotherapy for esophageal cancer
by: DONG Xiaohuan, LIU Jun, LI Hongxuan, CHENG Yan, LI Yue, YU Wen, CAI Xuwei, FU Xiaolong
Published: (2023-03-01)

Comparison of therapeutic outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A prospective observational cohort study
by: Yu-Wei Liu, et al.
Published: (2024-01-01)

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
by: Dongryul Oh, et al.
Published: (2020-08-01)

A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)Research in context
by: Rui Chen, et al.
Published: (2023-08-01)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
by: Chi Zhang, et al.
Published: (2023-01-01)

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study
by: Xiaobin Zhang, et al.
Published: (2020-03-01)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
by: Ali Kermani, et al.
Published: (2020-01-01)

A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
by: Chaoqi Zhang, et al.
Published: (2020-08-01)

MR radiomics predicts pathological complete response of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a multicenter study
by: Yunsong Liu, et al.
Published: (2024-01-01)

Recurrence timing and patterns incorporating lymph node status after neoadjuvant chemoradiotherapy plus esophagectomy for esophageal squamous cell carcinoma
by: Guihong Liu, et al.
Published: (2024-03-01)

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)
by: Hai-Bo Sun, et al.
Published: (2020-04-01)

Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
by: Li Jiang, et al.
Published: (2022-12-01)

Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery
by: Qingtao Qiu, et al.
Published: (2020-08-01)

The Comparative Effect of Definitive Chemoradiotherapy and Neoadjuvant Chemoradiotherapy Plus Surgery on One-Year Survival Rate of Esophageal Cancer Patients
by: Fatemeh Khanaki, et al.
Published: (2022-12-01)

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort
by: Wei‐Xiang Qi, et al.
Published: (2023-06-01)

Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
by: Xin Xu, et al.
Published: (2021-07-01)

Progress in Multimodal Treatment for Advanced Esophageal Squamous Cell Carcinoma: Results of Multi-Institutional Trials Conducted in Japan
by: Kazuo Koyanagi, et al.
Published: (2020-12-01)